Date(s) - June 24, 2021
7:00 pm EDT - 8:30 pm EDT
This on-line discussion will focus on understanding the current role of immunotherapy in treating cancer, explore promising new developments in the field and discuss immunotherapy’s potential for treating FLC. During the event, Mark Furth, FCF’s Scientific Director, will moderate a conversation with leading researchers in immunotherapy from Johns Hopkins University and St. Jude Children’s Research Hospital.
This discussion and Q&A session will be conducted as an interactive Zoom webinar and will begin at 7:00 pm Eastern time/4:00 pm Pacific time.
- Elizabeth Jaffee, MD
Deputy Director, The Sidney Kimmel Comprehensive Cancer Center
Professor of Oncology
Johns Hopkins Medicine
- Paul Thomas, PhD
Member, St. Jude Faculty
Department of Immunology
St. Jude Children’s Research Hospital
If participants are interested in learning more about cancer immunotherapy prior to the event, CRI has an excellent overview of the topic here.